- Home
- QH vs TCRT Comparison
QH vs TCRT Comparison
Compare QH & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QH
- TCRT
- Stock Information
- Founded
- QH 2012
- TCRT 1998
- Country
- QH China
- TCRT United States
- Employees
- QH 421
- TCRT N/A
- Industry
- QH Business Services
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- QH Consumer Discretionary
- TCRT Health Care
- Exchange
- QH Nasdaq
- TCRT Nasdaq
- Market Cap
- QH 6.6M
- TCRT 4.8M
- IPO Year
- QH 2020
- TCRT N/A
- Fundamental
- Price
- QH $6.70
- TCRT $2.32
- Analyst Decision
- QH
- TCRT
- Analyst Count
- QH 0
- TCRT 0
- Target Price
- QH N/A
- TCRT N/A
- AVG Volume (30 Days)
- QH 95.1K
- TCRT 339.2K
- Earning Date
- QH 08-28-2025
- TCRT 11-13-2025
- Dividend Yield
- QH N/A
- TCRT N/A
- EPS Growth
- QH N/A
- TCRT N/A
- EPS
- QH 0.80
- TCRT N/A
- Revenue
- QH $417,431,053.00
- TCRT $6,000.00
- Revenue This Year
- QH N/A
- TCRT $5,680,500.00
- Revenue Next Year
- QH N/A
- TCRT N/A
- P/E Ratio
- QH $8.29
- TCRT N/A
- Revenue Growth
- QH N/A
- TCRT N/A
- 52 Week Low
- QH $3.93
- TCRT $1.31
- 52 Week High
- QH $169.07
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- QH 26.97
- TCRT 48.81
- Support Level
- QH $6.01
- TCRT $2.15
- Resistance Level
- QH $7.07
- TCRT $2.40
- Average True Range (ATR)
- QH 0.60
- TCRT 0.20
- MACD
- QH 2.93
- TCRT 0.07
- Stochastic Oscillator
- QH 88.09
- TCRT 78.95
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.